7.80% p.a. Multi Barrier Reverse Convertible
Eli Lilly, Novo Nordisk, Roche
Valor
128208001
SIX Symbol
OACRCH
ISIN
CH1282080014
Currency
CHF
Bid (indicative)
{{ brochure.product.productFeed.bid | number:2 }}{{ brochure | quotingPercentage: brochure.product.productFeed.bid }}
250'000.00
Price on
{{ brochure.product.productFeed.date | timeFormat }}
{{ brochure.product.productFeed.date | dateShortFormat }}
Identifiers
128208001
CH1282080014
OACRCH
Yield Enhancement
Barrier Reverse Convertible
Callable Multi Barrier Reverse Convertible
1230
Figures
-39.56%
Parameters
Raiffeisen Switzerland Cooperative, St. Gallen, Switzerland
Quarterly
7.80% p.a.
Cash Settlement or Delivery of Underlying
Dirty (accrued interest included)
100%
CHF 1'000.00
CHF
CHF 250'000.00
CHF 0.00
Listed
Yes
Life Cycle
1.5 Years
22 Mar 2024
28 Mar 2024
28 Mar 2024
08 Apr 2024
08 Apr 2024
01 Oct 2025
08 Oct 2025
Barrier
59.00%
Continuous barrier observation (american)
28 Mar 2024 - 01 Oct 2025
Yes
Product Specific Features
100.00%
Performance
Market Price Initial Fixing Level Barrier Level Strike Level Distance to Strike
Eli Lilly
{{ underlyings['67114601'].currency }} {{ underlyings['67114601'].underlyingFeed.spot | number:2 }}
USD 777.96 USD 459.00 USD 777.96 12.11%
Novo Nordisk
{{ underlyings['67519173'].currency }} {{ underlyings['67519173'].underlyingFeed.spot | number:2 }}
DKK 881.30 DKK 519.97 DKK 881.30 -106.15%
Roche
{{ underlyings['67108970'].currency }} {{ underlyings['67108970'].underlyingFeed.spot | number:2 }}
CHF 229.70 CHF 135.52 CHF 229.70 15.35%
Cannot load the chart. Please try again later
Coupons
Payment Date Amount
08 Jul 2024 1.95%
08 Oct 2024 1.95%
10 Jan 2025 1.95%
08 Apr 2025 1.95%
08 Jul 2025 1.95%
08 Oct 2025 1.95%
Early Redemption
Observation Date Redemption Amount
01 Apr 2025 100.00%
01 Jul 2025 100.00%
Eli Lilly
Cannot load the chart. Please try again later
Eli Lilly
{{ underlyings['67114601'].currency }} {{ underlyings['67114601'].underlyingFeed.spot | number:2 }}
LLY UN
USD
USD 777.96
USD 458.9964
USD 777.96
12.1148%
NYSE
Novo Nordisk
Cannot load the chart. Please try again later
Novo Nordisk
{{ underlyings['67519173'].currency }} {{ underlyings['67519173'].underlyingFeed.spot | number:2 }}
NOVOB DC
DKK
DKK 881.30
DKK 519.967
DKK 881.30
-106.152%
OMX Nordic Exchange Copenhagen
Yes (12 Mar 2025)
Roche
Cannot load the chart. Please try again later
Roche
{{ underlyings['67108970'].currency }} {{ underlyings['67108970'].underlyingFeed.spot | number:2 }}
ROG SW
CHF
CHF 229.70
4.3535
CHF 135.523
CHF 229.70
15.3492%
SIX Swiss Exchange AG